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Abstract
Introduction: Infective endocarditis (IE) is still connected with high operative
mortality. Inflammatory markers are commonly used in monitoring patient clin-
ical condition. Respiratory burst and reactive oxygen species (ROS) are the main
way of pathogen elimination. Specificity of this process in the aspect of bacte-
rial infection is the key for correlation assessment between ROS and inflam-
matory markers in patients with IE. In the study, assessment of ROS as a clini-
cal indicator in IE was conducted.
Material and methods: During 2007/2008 in the Cardiosurgical Clinic of the
Medical University in Lodz there were 20 patients operated on for IE. The exam-
ined population consisted of 13 men and 7 women, aged from 23 to 74 years.
Inflammatory markers – leukocytosis (WBC), C-reactive protein (CRP), procalci-
tonin (PCT) and erythrocyte sedimentation rate (ESR) – were assessed preop-
eratively, on the 3rd, 7th, 12th and 21st day. Simultaneously, with the second venous
blood sample chemiluminescence (luminal enhanced whole blood chemilumi-
nescence) was carried out and used to assess ROS production. The results were
analyzed statistically.
Results: Positive correlation between ESR, CRP and ROS in the preoperative peri-
od was confirmed. An increase in ROS and a statistically significant increase in
inflammatory markers on the 3rd day were observed. The ROS normalized on
the 12th day. Marked individual variability was specific for the inflammatory
markers. Despite the significant decrease, not all of them achieved a normal
level at the last control point.
Conclusions: Assessment of ROS seems to be a universal parameter with pos-
sible application in patients with IE.
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Introduction
Reactive oxygen species (ROS) released during the respiratory burst
(RB) are the main protection from bacteria. Their impaired production as
in staphylococcal endocarditis results in a severe course of the disease [1].
On the other hand, their uncontrolled generation in the ROS-induced ROS-
release mechanism (RIRR) plays a negative role [2]. Postoperatively,
increased neutrophil activation due to secondary stimuli such as extra-
corporeal circulation (ECC) called ‘priming’ can be observed [3]. It is
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expressed by postoperative neutrophilia and their
increased capacity for aggregation as well as ROS
production. Additionally, increasing levels of acute
phase proteins during bacterial infection cause fur-
ther ROS release [4]. Acute phase proteins, used
commonly in treatment monitoring, are unspecific
components of the immunological response. They
take part in opso  nization, complement activation
and regulation of immunocompetitive cells, main-
ly leukocyte activation. Erythrocyte sedimentation
rate (ESR) alterations in the course of endocarditis
are the result of both plasma protein and cellular
blood composition changes such as anemia or
leukocytosis. So far, proposed schemes of treat-
ment monitoring in patients with infective endo-
carditis (IE) have proved unsatisfactory due to lack
of specificity of the laboratory parameters as well
as difficulty in their interpretation. Researchers con-
tinue to seek a parameter that will give rapid
responses about the indications for operation and
effectiveness of treatment, especially in clinically
difficult cases.
Aim of the study was establishing the possible
clinical application of ROS in patients with IE; com-
parison with other commonly used inflammatory
markers; the hypothetical usage of ROS level as an
indicator in monitoring the treatment of patients
operated on for IE.
Material and methods
The assessed population was composed of 20
patients with diagnosed IE, admitted to the Car-
diosurgical Clinic of the Medical University in Lodz
during 2007/2008 and subjected to the operation
of endocardial vegetation removal. Patients were
informed about the planned procedures and addi-
tional examinations. Written consent was obtained
from the patients if the procedures were not con-
sidered as part of the standard cardiosurgical man-
agement. The study protocol was approved by the
ethical committee of our institutions. The diagno-
sis of IE was established according to modified
Duke’s criteria [5]. The population consisted of 
7 women and 13 men, aged from 23 to 74 years.
The average age was 47.8. NYHA class III account-
ed for 11 patients (55%). A scheduled operation of
prosthetic valve implantation was conducted in 
18 patients. In one case it was a reimplantation.
Two patients were operated on due to life-threat-
ening indications in an active phase of IE. The com-
plete time of ECC ranged from 65 min to 158 min
(average 105 min). The cross clamp time varied from
48 min to 132 min, average 81 min. The heart was
perfused with a cold crystalloid cardioplegic solu-
tion, given antegrade and non-continuously (from
800 to 1600 ml). Patients had venous blood col-
lected and white blood cells (WBC), procalcitonin
(PCT), C-reactive protein (CRP) and ESR levels were
assessed at the control points: preoperatively and
on the 3rd, 7th, 12th and 21st day after the operation.
Simultaneously patients had LBCL carried out from
5 ml venous blood samples collected in the morn-
ing. On the basis of this examination respiratory
burst and ROS production by activated blood gran-
ulocytes (PMNs) and monocytes were determined.
The test was conducted within 30 min from the
blood collection. Nine hundred fourty-seven μl of
luminal warmed to 37°C within 60 min was added
to 3 μl of blood. Samples were incubated at 37°C
for 30 min. Luminescence was measured during
1 min using a 1251 luminometer (Bio-Orbit, Turku,
Finland). After adding 50 μl of formyl-methionyl-
leucyl-phenylalanine (fMLP) the measurement was
continued for the next 7 min. The measurements
were repeated 4 times for each patient and the
average value was calculated. Resting chemilumi-
nescence was given in aU/104 phagocytes (PMNs
and monocytes present in assessed sample) and
fMLP-stimulated total chemiluminescence (tCL) in
aU × s/104 phagocytes. Peak chemiluminescence
(pCL) and peak time were also recorded (respec-
tively presented in aU and s). 
Statistical analysis
Data were analyzed statistically. Values were
expressed as mean with standard deviation and
median with range. Spearman test was used to
determined the correlation between ROS produc-
tion and particular inflammatory markers. The dif-
ferences between chosen dependent variables were
analyzed by the Wilcoxon test. ANOVA Friedman
test with appropriate ‘post-hoc’ tests was used for
assessing the parameters’ variability with time. 
Results
Only one case of endocarditis was related to
a prosthetic valve. Preoperatively, Staphylococcus
as an etiological factor was estimated in 50% of
positive blood cultures. Fifty-five percent of all pre-
operative cultures were negative.
In the study a variable connection between the
particular assessed inflammatory markers and ROS
generation was found. A positive correlation was
found only between ROS and preoperative levels of
CRP and ESR (level of significance p < 0.05). Leuko-
cytosis correlated positively with tCL at the initial
control point and with peak time on the 7th post-
operative day. Surprisingly, there was no correla-
tion between ROS and PCT.
Although ROS level increased on the 3rd post-
operative day, it was not statistically significant.
However, during the 21-day observation rCL, tCL and
pCL started to decrease from the 3rd day. On the
21st day it reached the value before the operation.
On the 12th day a statistically significant (p < 0.05)
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decrease was noted. The difference between the
level of ROS on the 7th day and at subsequent
check points was statistically significant (p < 0.05).
The comparison between preoperative and post-
operative peak time showed a statistically signifi-
cant increase (p < 0.05). 
The analysis of WBC, CRP, ESR and PCT revealed
the highest increase of their values on the 3rd day.
At the subsequent control points a gradual decrease
of their levels was observed. For all these parame-
ters the differences were statistically significant 
(p < 0.05 for PCT and WBC, p < 0.02 for ESR, 
p < 0.0001 for CRP). Furthermore, individual vari-
ability of the particular inflammatory parameters’
normalization in the examined population was esti-
mated. A statistically significant positive correlation
between the preoperative values of CRP and remain-
ing inflammatory markers was noted (Table I). 
Discussion
The cardiosurgical operation of a patient with IE
is a model example of a slight balance between con-
trary immunological mechanisms. Simultaneously,
as a result of surgery and ECC usage, the systemic
inflammatory response syndrome (SIRS) develops
and stimulates the compensatory antiinflammato-
ry response syndrome (CARS). Additionally, the pres-
ence of a restricted bacterial focus modifies the
patient’s response to the surgical trauma.
In comparison to the preoperative values, neu-
trophilia and lymphopenia, which tend to normal-
ize within the next few days, can be observed [6].
The postoperative lymphopenia, caused by surgery-
induced lymphocyte apoptosis, is mainly responsi-
ble for the increased organism susceptibility to infec-
tion. It is especially significant in patients with IE [7].
Fransen et al. [8] assessed PMN activation by
evaluating the level of bactericidal permeability
increasing protein (BPI) in patients subjected to
CABG with or without ECC. Only in the first group
did BPI remain elevated and the increase occurred
during the aortic cross clamping. On the other hand,
Tarnok et al. [9] recorded decreased activation 
of neutrophils during cardiosurgical operations in
children. It was proven by decreased expression of
the adhesive molecules (LFA-1, Mac-1) and reduced
respiratory burst, both basal and PMA-stimulated
(PMA – phorbol-12-myristate-13-acetate). The
researchers explained this effect by selective filtra-
tion of PMNs with increased adhesion capacity and
their maintenance in the cardiopulmonary bypass
(CPB) device or lung capillaries. Our experience and
results confirm that the surgical procedure induces
neutrophil activation, oxidative burst in phagocytes
and ROS generation. However, a rapid decrease of
ROS in the early postoperative period (rCL, tCL, pCL)
is a sign of an effective cardiosurgical intervention
and uncomplicated recovery. Appropriate antibiot-
ic therapy was also proven to enhance the respira-
tory burst of neutrophils impaired during general
infections in neonates [10]. Consequently, the antibi-
otic therapy in our patients was effective.
Although the prolongation of postoperative peak
time in comparison to preoperative values was
observed on the 3rd day, only the difference with
the postoperative values from the 21st day was sta-
tistically significant. This may be related to impair-
ment of the respiratory burst, probably in the mech-
anism of exhaustion. This state may be connected
with increased susceptibility to recurrence of the
infection. In cases of high risk patients or with
worse prognosis, antibiotic therapy modification in
this period should be considered.
Monocyte suppression (lack of TNF-α release and
HLA-DR expression) may be a result of extensive
surgery. Grundmann et al. [11] discovered that ex
vivo monocyte blockade can be achieved with blood
from patients after CABG and returned by adding
anti-IL-10 and labetalol. Volk et al. [12] eliminated
catecholamine and cortisol stimulated IL-10 pro-
duction by applying the thoracic epidural block
(TEB). However, they did not obtain elevation in
monocyte activation. Hiesmayr et al. [13] observed
the increase of IL-10 only in cardiosurgical patients
in comparison to patients who underwent thoracic
surgery. Sbrana et al. [14] found an unspecific
increase in adhesion of monocytes and platelets as
a result of non-receptor membrane changes,
induced by ECC. Alterations in the RB level were not
present. They suggested that the detected IL-10,
responsible for monocyte suppression, was released
by myocardial lymphocytes. The researchers con-
ducted the examinations with blood from the coro-
nary sinus. That proves the local immunosupp  -
Time of measurement Preoperatively (T1) 3rd day (T2) 7th day (T3) 12th day (T4) 21st day (T5)
Average ± SD rCL 1.18 ±0.85 1.75 ±1.85 1.39 ±1.24 0.78 ±0.011 0.89 ±0.20
pCL 6.56 ±7.69 10.61 ±12.3 8.46 ±10.50 2.31 ±1.45 2.89 ±3.12
Min-max rCL 0.60-3.10 0.70-7.10 0.68-5.33 0.67-1.05 0.62-1.35
pCL 1.29-22.68 1.21-22.41 1.29-25.29 1.20-6.05 0.89-12.68
T2, T3, T4, T5 measurements in the postoperative period
Table I. Range and variability of alterations in ROS presentation relying on the basal and fMLP stimulated oxidative
burst
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ression. Simultaneously, lack of immunological
response suppression, connected with a leukocyte
activation decrease, is an unfavorable prognostic
factor [15].
Documentary data showed the role of IL-6,
whose alterations seemed to correlate more specif-
ically with the clinical response to therapy [16]. On
the other hand, ECC induces an unspecific increase
of IL-6 with maximal values between postoperative
hours 6 and 24 [17]. The superiority of ROS relies
on its availability. 
Studies were also carried out to assess the role
of lipopolysaccharide-binding protein (LBP) in the
course of endocarditis. Some results are promising.
Wollmer et al. [18] noted high specificity and sen-
sitivity (> 90%) of this marker. Simultaneously, they
estimated the synchrony of LBP and CRP alterations.
They confirmed the clinical value of CRP in patients
with IE. The LBP showed superiority to CRP only in
patients with recurrence of IE during the in-hospi-
tal antibiotic therapy. The increase of LBP was
observed 3 days prior to the increase of the CRP .
According to our results, CRP does not seem to be
specific enough for the assessment of a patient with
IE and does not show superiority to ESR or WBC.
Despite effective therapy it does not normalize in
some patients (the median value on the 21st day
was 9.3 mg/l). Other researchers did not confirm the
diagnostic and prognostic value of LBP, which could
be caused by the application of other methods for
measurements, as Wollmer suggested. The LBP lev-
el was also markedly modified by the surgery. The
immediate postoperative period (24-72 h) did not
differ in patients with IE or valvular heart disease.
In contrast, Ostrowki et al. [19] observed even 3-fold
postoperative (on the 3rd day) increase in patients
with IE in comparison to patients operated on for
valvular diseases. In view of the aforementioned
results of Tarnok, postoperative RB stimulation in
patients with IE may be related to the release of bac-
terial antigens. It cannot be excluded that in patients
with infection the hyperreactive immune system
reacts more extensively to the surgical procedure.
An important issue, demanding an individual
clinical approach, is population variability in the
response to ECC, reflected by the variable antiox-
idative capacity (AOC) of the plasma [20]. Unavoid-
able tissue hypoxia during the operation with sub-
sequent reperfusion increases the production of
inflammatory cytokines and ROS [21]. Bugajski 
et al. [22] observed that hypoxic myocardial cells
produce a factor stimulating plasma neutrophils. It
was indirectly confirmed to be endothelin 1. The
average time of aortic cross clamping lasting 81 min
allowed us to reduce the ROS alterations modified
by hypoxia. Documentary data show that 4-h mild
or acute hypoxia markedly affects the ROS value
and induces cardioblast apoptosis [23]. In each
patient we noted increased ROS generation and
analogical time variability, which is a huge advan-
tage in comparison to highly individualized inflam-
matory markers. A further advantage is its faster
normalization in comparison to inflammatory mark-
ers (the median on the 12th day vs. the 21st day for
WBC, ESR, PCT or CRP). What is more, the ROS con-
tent in patients’ blood, reflecting the oxidative
stress, inflammation advancement or correlating
with lipid metabolism, does not undergo such sud-
den alterations [24]. It would be reasonable to
assess ROS only preoperatively, on the 3rd and 12th
postoperative day.
Although operative mortality has decreased
(30% in the 1970s), it continues to be high and
ranges from 7.5% to 10% [25]. In our practice it also
reached 10%. Based on the authors’ experience and
knowledge, only acute mitral and aortic insuffi-
ciency in the course of endocarditis demands
urgent surgical intervention due to no possibility
for compensatory mechanism development and the
life-threatening state. According to the newest
guidelines, heart failure, uncontrolled infection and
prevention of peripheral emboli are the indications
for surgery (emergent or urgent) [26].
Surprisingly, no correlation between ROS and
PCT was noted. As PCT is a principal marker assess-
ing the bacteremia advancement [27], it should
have correlated with ROS and RB, stimulated by the
bacterial infection. Probably, the lack of correlation
between these parameters is a result of various and
sudden kinetics of their alterations. Some authors
[17] suggested not determining the absolute val-
ues of PCT but following the dynamics of its vari-
ability. In our study, comparing the median values
from the 7th vs. the 12th postoperative day, we
observed a 3-fold decrease of PCT. It should be kept
in mind that PCT increases moderately during
extensive surgery [27]. This marker, which should
achieve normal limits within 2 days on condition of
proper antibiotic therapy, is regarded as being more
specific and sensitive than CRP, leukocytosis or 
IL-6 [17, 27]. Our analysis has not confirmed its
superiority in patients with IE [28]. 
The outcomes of our study show the compati-
bility between ESR, CRP and LBCL variability over
time. They also prove the uselessness of the com-
mon control of the above two parameters in
patients with IE, as was also confirmed by other
researchers. They proved mild compatibility between
them (67%) and the superiority of CRP in inflam-
matory diseases [29]. The correlation between ROS
and CRP is not so obvious in the aspect of the men-
tioned CRP regulative role of leukocyte activation in
the infection. This protein takes part in the inhibi-
tion of neutrophil chemotaxis and has a slight
chemotactic activity on monocytes. Furthermore, it
inhibits ROS production, even stimulated by fMLP,
which is interpreted as its protective effect on tis-
sues, defending them against oxidative stress [30].248 Arch Med Sci 2, April / 2012
On the other hand, it is known to have a negative
role in the induction of ROS production by the
endothelial progenitor cells, resulting in their
increased tendency to apoptosis [31]. The choice of
ROS examination seems to be more appropriate also
in the view of unspecific CRP, whose increase is
observed in burns, myocardial infarction, acute pan-
creas inflammation, pregnancy, neoplasms, obesity
and renal dysfunction [32, 33]. Other studies also
confirmed the connection between ROS decrease
and patient clinical improvement [19]. The positive
correlation between the increase of ROS and the
inflammatory markers, found in this study, is indi-
rect evidence of their clinical impact.
The clinical utility of new tests (FORT) assessing
the content of ROS in patients’ blood was found in
myocardial infarction [34]. Their application in
patients with endocarditis would be a fast indica-
tor of disease progression.
It should be emphasized that the choice of mon-
itoring parameter depends on the way of treat-
ment: conservative or surgical. It should be includ-
ed in assessment of inflammatory markers or
cytokines. In our opinion ROS level could be a uni-
versal indicator, which does not exclude the indi-
vidualized approach in each episode of IE. The ROS
may have a particular implication in high-risk
patients, especially when the assays of inflamma-
tory markers are confusing. 
Our study has some important limitations. They
mainly concern the small number of enrolled
patients, which could have disturbed the statisti-
cal assessment. However, the number of patients
operated on annually for endocarditis in our clinic
is 20-30 patients. The purpose of this research was
to assess only the most commonly used biochem-
ical markers. These selected markers were also tak-
en into consideration in our previous study [28].
In conclusion, ROS level assessment in patients
with IE seems to have wider clinical implications
than monitoring inflammatory markers such as
WBC, CRP, PCT or ESR. The ROS decrease within the
complex treatment of patients with endocarditis
was confirmed. Further studies are needed to eval-
uate the specificity of ROS examination in patients
with IE to exclude the marked influence of respira-
tory hypoxia, obesity, diabetes and other factors
inducing RB and also other ways of ROS genera-
tion. The contribution of tissue trauma seems to
have reduced the impact on the RB and ROS level.
FORT application could ensure a rapid, non-inva-
sive, simple and economical indicator in monitor-
ing patients with IE.
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